OUTCOMES WITH USE OF ANTI-THYMOCYTE GLOBULIN FOR TREATMENT OF ACUTE TCMR IN STANDARD RISK KIDNEY TRANSPLANTATION

  Back

13 Apr 2024 6:15 p.m. 7:15 p.m.

WCN24-AB-1013, Poster Board= SAT-218

Rabeea Azmat Poster Presenter